Continuous cerebrovascular reactivity monitoring in moderate/severe traumatic brain injury: a narrative review of advances in neurocritical care. (April 2020)

• Record Type: Journal Article
• Authors: Zeiler, Frederick A.; Ercole, Ari; Czosnyka, Marek; Smielewski, Peter; Hawryluk, Gregory; Hutchinson, Peter J.A.; Menon, David K.; Aries, Marcel
• Is Part Of: British journal of anaesthesia. Volume 124:Number 4(2020)
• Page Start: 440
• Page End: 453
• Publication Date: 2020-04
• Subjects: cerebral autoregulation -- cerebrovascular reactivity -- neurocritical care -- traumatic brain injury; Anesthesiology -- Periodicals; Anesthesia -- Periodicals; 617.9605
• DOI: 10.1016/j.bja.2019.11.031
• Languages: English
• ISSNs: 0007-0912

Abstract

Summary: Impaired cerebrovascular reactivity in adult moderate and severe traumatic brain injury (TBI) is known to be associated with worse global outcome at 6–12 months. As technology has improved over the past decades, monitoring of cerebrovascular reactivity has shifted from intermittent measures, to experimentally validated continuously updating indices at the bedside. Such advances have led to the exploration of individualised physiologic targets in adult TBI management, such as optimal cerebral perfusion pressure (CPP) values, or CPP limits in which vascular reactivity is relatively intact. These targets have been shown to have a stronger association with outcome compared with existing consensus-based guideline thresholds in severe TBI care. This has sparked ongoing prospective trials of such personalised medicine approaches in adult TBI. In this narrative review paper, we focus on the concept of cerebral autoregulation, proposed mechanisms of control and methods of continuous monitoring used in TBI. We highlight multimodal cranial monitoring approaches for continuous cerebrovascular reactivity assessment, physiologic and neuroimaging correlates, and associations with outcome. Finally, we explore the recent 'state-of-the-art' advances in personalised physiologic targets based on continuous cerebrovascular reactivity monitoring, their benefits, and implications for future avenues of research in TBI.